112
Participants
Start Date
January 10, 2025
Primary Completion Date
August 31, 2028
Study Completion Date
November 30, 2028
R-CMOP Regimen
Rituximab intravenous drip, Cyclophosphamide intravenous drip, Liposomal Mitoxantrone intravenous drip, Vincristine intravenous drip, Prednisone orally
R-CHOP Regimen
Rituximab intravenous drip, Cyclophosphamide intravenous drip, Doxorubicinin intravenous drip, Vincristine intravenous drip, Prednisone orally
RECRUITING
The Fifth Affiliated Hospital of Guangzhou Medical University., Guangzhou
NOT_YET_RECRUITING
Fujian Provincial Cancer Hospital, Fuzhou
NOT_YET_RECRUITING
Gansu Provincial Cancer Hospital, Lanzhou
NOT_YET_RECRUITING
The Affiliated Hospital of Guangdong Medical University, Guangzhou
NOT_YET_RECRUITING
Shenzhen People's Hospital, Shenzhen
RECRUITING
The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai
NOT_YET_RECRUITING
Guangxi Zhuang Autonomous Region Cancer Hospital, Guilin
NOT_YET_RECRUITING
Ganzhou Cancer Hospital, Ganzhou
NOT_YET_RECRUITING
Jiangxi Provincial Cancer Hospital, Nanchang
NOT_YET_RECRUITING
Beijing Tongren Hospital, Beijing
Sun Yat-sen University
OTHER